MEDICA Newsletter
Social Media
More about…
- 3D-Druck
- Adipositas
- Alter
- Alternative Medizin
- Alzheimer
- Anästhesie
- Arzneimittel
- Augen
- Ausbildung
- Behandlung
- Beleuchtung
- Bildgebung
- Biofeedback
- Biokompatibel
- Biomarker
- Biotechnologie
- Blut
- Bluthochdruck
- CT
- Chirurgie
- Darm
- Demenz
- Depression
- Desinfektion
- Diabetes
- Diagnostik
- Elektronische Patientenakte
- Epilepsie
- Erbmaterial
- Ernährung
- Fitness
- Forschung
- Frauen
- Früherkennung
- Geburt
- Gehirn
- Genetik
- Geräte
- Gesundheitspolitik
- Haut
- Herz
- Herz-Kreislauf
- Hygiene
- Immunsystem
- Implantat
- Infektionskrankheit
- Informationstechnologie
- Intensivmedizin
- Kinder
- Kommunikation
- Krankenhaus
- Krebs
- Künstliche Intelligenz
- Labor
- Laser
- Lunge
- MRT
- Magen
- Medizinische Apps
- Medizinmarkt
- Mikrosystemtechnik
- Minimal-Invasiv
- Nanotechnologie
- Neurologie
- Notfallmedizin
- Operation
- Optimierung
- Optische Technologien
- Organe
- Parkinson
- Pathologie
- Patienten
- Personalisierte Medizin
- Pflege
- Physiotherapie
- Prothese
- Psychologie
- Radiologie
- Regenerative Medizin
- Rehabilitation
- Rheuma
- Risiken
- Robotik
- Röntgengeräte
- SARS-CoV-2/COVID-19
- Schlaf
- Schlaganfall
- Schmerzen
- Schwangerschaft
- Senioren
- Sicherheit
- Sinne
- Smart textiles
- Software
- Sport
- Stammzellen
- Stent
- Sterilisation
- Telemedizin
- Therapie
- Tissue Engineering
- Transplantation
- USA
- Ultraschall
- Virtual Reality
- Wearables
- Weltgesundheit
- Werkstoffe
- Wundheilung
- Zellen
- Ärzte
Wearable microfluidic sensor to measure lactate concentration in real time
25/02/2021
Scientists develop new biosensing device to chemically monitor the state of muscles during physical exercise.
Mass spectrometry: novel gel electrophoresis technique for rapid biomarker diagnosis
19/02/2021
Mass spectrometry (MS) is a powerful method for biomarker analysis because it enables highly sensitive and accurate measurement of target molecules in clinical samples. The application of MS to clinical diagnosis, such as neonatal metabolic screening, has been progressing with a focus on metabolite markers.
World Cancer Day 2021
04/02/2021
Everyone knows it, everyone has heard of it: cancer. It is still one of the most common causes of death. Every year on 4 February, the World Cancer Organisation draws attention to this issue with World Cancer Day. By providing information, it gives hope to sufferers and non-affected people on how to take preventive action against the disease.
Intelligent implants: when the material is the key to the solution
01/02/2021
Today we use implants to stabilize or compensate for injuries inside the body and to aid in the healing process. Implants cannot act autonomously and treat the patient if they deem it necessary. However, it is just a matter of time before this happens because research on intelligent implant materials that respond to stimuli is on the cusp of a breakthrough.
AI: individualized cancer therapy soon to be faster
29/01/2021
The treatment of cancer with new, individualized cell therapies is usually very costly and lengthy. Before treatment can take place, patients often have to wait a long time for individualized therapeutics to be produced and they lose valuable time.
Blood group co-determines composition of the intestinal microbiome
21/01/2021
Chronic inflammatory bowel disease (CIBD) in particular is suspected to be closely linked to the composition and (im-)balance of the intestinal microbiome. However, the causal relationship between the microbiome and the development of disease and determining factors of the composition of the microbiome in the individual are still largely unexplained.
Detecting COVID-19 antibodies in 10-12 seconds
15/01/2021
Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic. In addition to testing, the platform will help to quantify patient immunological response to the new vaccines with precision.
Vivatmo me: monitor your asthma treatment at home
01/01/2021
Allergic asthma is a chronic disease that makes regular monitoring essential to keep it under control. This is the only way to determine whether the prescribed medication is effective or whether the patient needs a treatment adjustment. Vivatmo me is a breath analyzer device for home use and helps keep asthma patients safe and confident between visits to the doctor.
Cardiac diagnostics – prompt and personalized
08/11/2019
If physicians suspect an acute myocardial infarction, they first order an ECG. This test is very established and allows cardiologists to quickly diagnose acute heart attacks – though the test does not detect less common heart attack symptoms. So far, those patients had to wait up to twelve hours before a heart attack could be accurately diagnosed or ruled out. But things are about the change.
Early detection: Tattoo signals cancer – and more
09/07/2018
People who are not ill and do not show any symptoms typically do not visit the doctor. And while most people know that preventive medical checkups for cancer, for example, are important, they still avoid them. They tend to be very hesitant because the doctor might detect a serious illness. In the future, a new type of implant could make it easier to go to a screening test.
Personalized cancer medicine – Best possible treatment with TherapySelect
30/04/2018
Medicine is getting more and more personalized. This is particularly interesting for oncology, since a cancer is as individual as the respective patient. When choosing a therapy, both the characteristics of the tumor and the personal characteristics of the patient must be considered. To see exactly what this looks like, we visited the diagnostics company TherapySelect, based in Heidelberg.
Personalized medicine: a paradigm shift is gaining momentum
01/03/2018
Personalized medicine does not follow a "one-size-fits-all" treatment approach but emphasizes a "tailor-made" paradigm, meaning a treatment is customized to each individual person's case. For patients, this increases the chances of treatment success and means fewer side effects. While the approach originates in the field of oncology, it is now also increasingly applied to other disease patterns.